Yüklüyor......
Chimeric Antigen Receptor T-Cell Therapy in Glioblastoma: Current and Future
Glioblastoma (GBM) is a highly aggressive glioma with an extremely poor prognosis after conventional treatment. Recent advances in immunotherapy offer hope for these patients with incurable GBM. Our present review aimed to provide an overview of immunotherapy for GBM, especially chimeric antigen rec...
Kaydedildi:
| Yayımlandı: | Front Immunol |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7669545/ https://ncbi.nlm.nih.gov/pubmed/33224149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.594271 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|